LMO3
LMO3 (LIM domain only 3) is a member of the rhombotin family of cysteine-rich LIM domain oncogenes. It is also known as Rhom-3, DAT1 and RBTNL2, and the gene is predominantly expressed in the brain. Browse Assay Genie's current range of LMO3 research reagents below, or read on for the biology behind the target.
LMO3 is the protein product of a gene belonging to the rhombotin family of cysteine-rich LIM domain oncogenes. In HGNC it is placed in the LIM domain containing gene group. The summary sources used for this page do not give a detailed molecular mechanism for LMO3, so its function is best understood through its family relationships and its pattern of expression.
According to the NCBI Gene summary, the LMO3 gene is predominantly expressed in the brain. Many alternatively spliced transcript variants have been found, which is worth bearing in mind when designing experiments that depend on a particular transcript or protein form. Orthologous genes, named Lmo3, are present in mouse and rat, allowing the gene to be studied in common rodent models.
The name reflects the family history. LMO3 was formerly called rhombotin-like 2 (RBTNL2) and is also known as Rhom-3 and DAT1. Its relatives LMO1 and LMO2 are located on chromosome 11 and have been reported to be involved in chromosomal translocations in T-cell leukaemia, which is why the family is described as oncogenic. LMO3 itself is encoded on a different chromosome, and researchers studying the LMO3 gene or LMO3 protein often compare it with other LIM-only proteins such as LMO2 and LMO4.
LMO3 is predominantly expressed in the brain, making it a relevant gene for studies of brain-enriched expression.
LMO3 belongs to the rhombotin family of cysteine-rich LIM domain oncogenes, which is of interest in cancer research.
As a member of the LIM domain containing gene group, LMO3 is useful for comparative work across LIM-only proteins.
Many alternatively spliced transcript variants of LMO3 have been found, supporting studies of isoform-level gene regulation.
LMO3 is a member of the rhombotin family of cysteine-rich LIM domain oncogenes and is predominantly expressed in the brain. The sources used here do not provide a detailed molecular function, so its role is usually inferred from family relationships and expression.
LMO3 stands for LIM domain only 3. Aliases and previous symbols include Rhom-3, DAT1 and RBTNL2, and the previous name was rhombotin-like 2. Many alternatively spliced transcript variants have been reported for the gene.
LMO3 belongs to the same rhombotin family as LMO1 and LMO2. LMO1 and LMO2, on chromosome 11, have been reported in chromosomal translocations in T-cell leukaemia. Mouse and rat both have an Lmo3 ortholog; check the datasheet of any product for its validated reactivity.
Other LIM domain only proteins related to LMO3 with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8TAP4; product specifications from Assay Genie datasheets.